The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Among the hundreds of thousands of chemical compounds produced by plants, some may hold the key to treating human ailments and diseases. But recreating these complex, naturally occurring molecules in ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Authorities said they found about 56 grams of Methamphetamine (ICE), about 112 grams of crack and powder Cocaine, about 500 ...